Facebook Linkedin RSS Twitter Youtube
Home 2024

Uterine cancer

Amgen Opts-in on Generate:Biomedicines Collaboration for Drug Development
Artificial Intelligence

Amgen Opts-in on Generate:Biomedicines Collaboration for Drug Development

The Genomic and Epigenomic Landscape of HPV in Cervical Cancer
Cancer

The Genomic and Epigenomic Landscape of HPV in Cervical Cancer

Viral-Bacterial Coinfection Can Reprogram Cells, Cause Cancer
Cancer

Viral-Bacterial Coinfection Can Reprogram Cells, Cause Cancer

Microbiome May Identify Female Precancer Risk from HPV
Cancer

Microbiome May Identify Female Precancer Risk from HPV

Cancer and Metabolic Disorders Linked with Testosterone Levels in Both Sexes, but with Differences
Cancer

Cancer and Metabolic Disorders Linked with Testosterone Levels in Both Sexes, but with Differences

Endometrial Organoids Represent Disease Processes and Drug Sensitivities
Cancer

Endometrial Organoids Represent Disease Processes and Drug Sensitivities

Novel Ovarian Cancer Diagnostic May Eliminate Need for Exploratory Surgery
Cancer

Novel Ovarian Cancer Diagnostic May Eliminate Need for Exploratory Surgery

Cervical Microbiome May Promote Cancer
Cancer

Cervical Microbiome May Promote Cancer

After Patient Dies, FDA Imposes Clinical Hold on Trial of Advaxis/AstraZeneca Combination
Cancer

After Patient Dies, FDA Imposes Clinical Hold on Trial of Advaxis/AstraZeneca Combination

FDA Approves Cervical-Cancer-Related HPV Test
Cancer

FDA Approves Cervical-Cancer-Related HPV Test

123...9Page 1 of 9
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.